Bmpr2 驱动狼疮性肾炎中肾小球内皮细胞的异常激活与损伤
研究通过单核 RNA 测序分析狼疮性肾炎患者和小鼠模型的肾组织,发现 Bmpr2 在肾小球内皮细胞中显著上调,并通过 SMA- 和 MAD 相关蛋白依赖通路促进内皮细胞增殖、迁移及炎症表型。C5a 是 Bmpr2 上调的关键上游诱导因子,靶向 BMPR2 或 C5a 信号可改善狼疮性肾炎。
要点
- Bmpr2 上调是狼疮性肾炎肾小球内皮细胞激活和损伤的核心原因。
- Bmpr2 高表达的肾小球内皮细胞促进巨噬细胞向炎症表型分化。
- C5a 介导肾小球内皮细胞中 Bmpr2 表达增加。
核心结论
- BMPR2 是狼疮性肾炎中肾小球内皮细胞损伤和巨噬细胞介导炎症的关键调节因子。
- 靶向 BMPR2 或其上游激活因子如 C5a,可有效治疗并改善狼疮性肾炎。
研究设计与样本
- 对狼疮性肾炎患者和小鼠模型的肾组织进行单核 RNA 测序(snRNA-seq),研究肾小球内皮细胞的转录改变。
- 在两种狼疮性肾炎模型(降植烷诱导的狼疮性肾炎和 Murphy Roths large/lpr 小鼠)中验证发现。
- 使用基因修饰小鼠和培养细胞进一步验证关键发现。
主要发现
- Bmpr2 在狼疮性肾炎患者和小鼠模型的肾小球内皮细胞中均显著上调。
- Bmpr2 表达升高与肾小球内皮细胞增殖和迁移增强以及黏附分子(Vcam1、Icam1)表达增加相关。
- BMPR2 激活 SMA- 和 MAD 相关蛋白依赖通路,上调下游靶点 ID1 和 ID3,促进肾小球内皮细胞过度激活。
- Bmpr2 过表达放大肾小球内皮细胞增殖和迁移,而用 DMH2 抑制 DNA 结合抑制因子信号或内皮特异性敲除 Bmpr2 可减弱这些效应。
- 靶向 BMPR2 信号减少 CD86+ 巨噬细胞浸润狼疮性肾炎肾脏;共培养实验证实 Bmpr2 激活的肾小球内皮细胞促进巨噬细胞向炎症表型分化。
临床怎么用
- 补体成分 C5a 被确定为肾小球内皮细胞中 Bmpr2 的关键上游诱导因子。
- 用 C5aR1 拮抗剂 PMX-53 抑制 C5a 信号可有效抑制 Bmpr2 上调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Upregulation of Bmpr2 was identified as a central cause of glomerular endothelial cell activation and injury in lupus nephritis. Glomerular endothelial cells with elevated Bmpr2 expression promoted inflammatory differentiation of macrophages. C5a mediated the increase in Bmpr2 expression in glomerular endothelial cells. BACKGROUND: Lupus nephritis, a severe complication of SLE, is closely associated with the abnormal activation of glomerular endothelial cells. Despite its significance, the core mechanisms underlying glomerular endothelial cell activation remain elusive. METHODS: We performed single-nucleus RNA sequencing (snRNA-seq) on kidney tissues from lupus nephritis patients and mouse models to investigate transcriptional alterations in glomerular endothelial cells and validated our findings in two lupus nephritis models: pristane-induced lupus nephritis and murphy roths large/lpr mice. Genetically modified mice and cultured cells were used to further validate the key discoveries. RESULTS: Bmpr2 was identified as a critical regulator, showing significant upregulation in glomerular endothelial cells from both lupus nephritis patients and mouse models. Elevated Bmpr2 expression correlated with enhanced glomerular endothelial cell proliferation and migration and increased expression of adhesion molecules (Vcam1, Icam1). BMPR2 activated SMA- and MAD-related proteins-dependent pathways, leading to the upregulation of downstream targets ID1 and ID3, thereby promoting glomerular endothelial cell hyperactivation. Bmpr2 overexpression amplified glomerular endothelial cell proliferation and migration, whereas inhibition of inhibitor of DNA binding signaling by 4-[6-[4-[2-(4-Morpholinyl)ethoxy]phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline (DMH2) or endothelial-specific Bmpr2 knockout attenuated these effects. Moreover, targeting BMPR2 signaling reduced the infiltration of CD86+ macrophages into lupus nephritis kidneys. Coculture experiments confirmed that Bmpr2-activated glomerular endothelial cells promoted macrophage differentiation into an inflammatory phenotype. Complement component C5a was identified as a critical upstream inducer of Bmpr2 in glomerular endothelial cells, and inhibition of C5a signaling with the C5aR1 antagonist PMX-53 effectively suppressed Bmpr2 upregulation. CONCLUSIONS: These findings highlight BMPR2 as a key regulator of glomerular endothelial cell injury and macrophage-mediated inflammation in lupus nephritis. Targeting BMPR2 or its upstream activators, such as C5a, effectively treated and improved lupus nephritis.
引用
- Qing J, Wen J, Wang X, et al. Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis. J Am Soc Nephrol. 2025. PMID: 40982334. doi:10.1681/ASN.0000000856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。